Your browser doesn't support javascript.
loading
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.
Imbert, Caroline; Montfort, Anne; Fraisse, Marine; Marcheteau, Elie; Gilhodes, Julia; Martin, Elodie; Bertrand, Florie; Marcellin, Marlène; Burlet-Schiltz, Odile; Peredo, Anne Gonzalez de; Garcia, Virginie; Carpentier, Stéphane; Tartare-Deckert, Sophie; Brousset, Pierre; Rochaix, Philippe; Puisset, Florent; Filleron, Thomas; Meyer, Nicolas; Lamant, Laurence; Levade, Thierry; Ségui, Bruno; Andrieu-Abadie, Nathalie; Colacios, Céline.
Afiliação
  • Imbert C; Inserm UMR1037, Cancer Research Center of Toulouse, 31037, Toulouse, France.
  • Montfort A; Equipe Labellisée Ligue Contre Le Cancer, 31037, Toulouse, France.
  • Fraisse M; Université Toulouse III-Paul Sabatier, 31062, Toulouse, France.
  • Marcheteau E; Inserm UMR1037, Cancer Research Center of Toulouse, 31037, Toulouse, France.
  • Gilhodes J; Equipe Labellisée Ligue Contre Le Cancer, 31037, Toulouse, France.
  • Martin E; Université Toulouse III-Paul Sabatier, 31062, Toulouse, France.
  • Bertrand F; Inserm UMR1037, Cancer Research Center of Toulouse, 31037, Toulouse, France.
  • Marcellin M; Equipe Labellisée Ligue Contre Le Cancer, 31037, Toulouse, France.
  • Burlet-Schiltz O; Université Toulouse III-Paul Sabatier, 31062, Toulouse, France.
  • Peredo AG; Inserm UMR1037, Cancer Research Center of Toulouse, 31037, Toulouse, France.
  • Garcia V; Equipe Labellisée Ligue Contre Le Cancer, 31037, Toulouse, France.
  • Carpentier S; Université Toulouse III-Paul Sabatier, 31062, Toulouse, France.
  • Tartare-Deckert S; Institut Universitaire du Cancer Toulouse, Oncopôle, 31059, Toulouse, France.
  • Brousset P; Institut Claudius Regaud, 31300, Toulouse, France.
  • Rochaix P; Institut Universitaire du Cancer Toulouse, Oncopôle, 31059, Toulouse, France.
  • Puisset F; Institut Claudius Regaud, 31300, Toulouse, France.
  • Filleron T; Inserm UMR1037, Cancer Research Center of Toulouse, 31037, Toulouse, France.
  • Meyer N; Equipe Labellisée Ligue Contre Le Cancer, 31037, Toulouse, France.
  • Lamant L; Université Toulouse III-Paul Sabatier, 31062, Toulouse, France.
  • Levade T; Université Toulouse III-Paul Sabatier, 31062, Toulouse, France.
  • Ségui B; Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, 31077, Toulouse, France.
  • Andrieu-Abadie N; Université Toulouse III-Paul Sabatier, 31062, Toulouse, France.
  • Colacios C; Centre National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, 31077, Toulouse, France.
Nat Commun ; 11(1): 437, 2020 01 23.
Article em En | MEDLINE | ID: mdl-31974367
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Fosfotransferases (Aceptor do Grupo Álcool) / Resistencia a Medicamentos Antineoplásicos / Melanoma Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Fosfotransferases (Aceptor do Grupo Álcool) / Resistencia a Medicamentos Antineoplásicos / Melanoma Tipo de estudo: Prognostic_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França